The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Diagnosing Mental Illness with the Perspectives Approach
Diagnosing Mental Illness with the Perspectives Approach
Could T Cells Lead to New MS Treatments?
Could T Cells Lead to New MS Treatments?
Seeking Out Symptoms of Broken Heart Syndrome
Seeking Out Symptoms of Broken Heart Syndrome
The Future of Restoring Functionality in Stroke Survivors
The Future of Restoring Functionality in Stroke Survivors
Refocusing Our Efforts on Advancing Technology to Help Stroke Survivors
Refocusing Our Efforts on Advancing Technology to Help Stroke Survivors
Treatment of Progressive MS: Why, Who, When, How
Treatment of Progressive MS: Why, Who, When, How
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Diagnostic Challenges of Spinal Cord Lesions in MS
The Diagnostic Challenges of Spinal Cord Lesions in MS
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Multiple Sclerosis Physician Resources
Multiple Sclerosis Physician Resources
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
